Detalhe da pesquisa
1.
Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged ⩾6 Years with Cystic Fibrosis and at Least One F508del Allele: A Phase 3, Open-Label Clinical Trial.
Am J Respir Crit Care Med
; 208(1): 68-78, 2023 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37154609
2.
Chronic daily respiratory care needs in people with cystic fibrosis treated with highly effective cystic fibrosis transmembrane conductance regulator modulators.
Curr Opin Pulm Med
; 29(6): 580-586, 2023 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37611027
3.
Human Mesenchymal Stem Cell (hMSC) Donor Potency Selection for the "First in Cystic Fibrosis" Phase I Clinical Trial (CEASE-CF).
Pharmaceuticals (Basel)
; 16(2)2023 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37259368
4.
A phase I study assessing the safety and tolerability of allogeneic mesenchymal stem cell infusion in adults with cystic fibrosis.
J Cyst Fibros
; 22(3): 407-413, 2023 May.
Artigo
Inglês
| MEDLINE | ID: mdl-36549988
5.
The use of tobramycin for Pseudomonas aeruginosa: a review.
Expert Rev Respir Med
; 16(5): 503-509, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35320051
6.
Epidemiology of Eosinophilic Esophagitis in Patients with Cystic Fibrosis: A Population-Based 5-Year Study.
Pediatr Gastroenterol Hepatol Nutr
; 25(4): 283-292, 2022 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-35903489
7.
Eosinophilic esophagitis in cystic fibrosis: A case series with long-term follow-up.
Pediatr Pulmonol
; 57(6): 1557-1561, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35355445
8.
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks.
J Cyst Fibros
; 19(1): 34-39, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31126900
9.
Inflammation in cystic fibrosis: An update.
Pediatr Pulmonol
; 53(S3): S30-S50, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-29999593
10.
Powerful tools for genetic modification: Advances in gene editing.
Pediatr Pulmonol
; 52(S48): S15-S20, 2017 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-28960896